Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Acorda Therapeutics Inc. -- Ignore unavailable to you. Want to Upgrade?

To: quantman who wrote (103)	1/28/2010 7:05:08 AM
From: kenhott	Respond to of 120

I think maybe everyone should come up with his/her own personal views on sales like you. My own opinion about ACOR in general has pretty much been posted already. I personally have to figure out how I am going to handle the ACOR stock after the FDA decision. I try to be a strategic trader/investor and in general do not just buy/sell and hold. Personally I make too many mistakes if I just buy/sell and forget. One add'l thought would be that I don't know if ACOR mgt would like to be taken over. In other words, everyone has a price, but I am not sure they would go at like $40. There are at least a couple of examples out there of companies not taking an offer which turned out to be the high stock price point.